PBM Transparency Requirements Needed To Protect Generic Switches – NCPA
This article was originally published in The Pink Sheet Daily
Executive Summary
A California bill mandating PBM disclosures related to drug substitution should be signed into law, the community pharmacists association says, disputing criticism of the proposal from the Federal Trade Commission. PCMA opposes the measure.